Relationship between dietary intake components and hepatic fibrosis in those with obesity before and 1 year after bariatric surgery

Nutrition. 2023 Oct:114:112095. doi: 10.1016/j.nut.2023.112095. Epub 2023 May 31.

Abstract

Objectives: Non-alcoholic fatty liver disease is highly prevalent in the bariatric population but not all patients develop liver fibrosis. Considering that fibrosis may affect clinical outcomes, it is important to assess and treat contributing factors. In this population, it is not clear whether dietary intake is a contributor. The objective was to determine the relationship between dietary intake components and liver fibrosis before and 1 y after Roux-en-Y gastric bypass (RYGB).

Methods: This was a prospective cross-sectional (n = 133) study conducted between 2013 and 2022. In addition, a subgroup of 44 patients were followed for 1 y post-RYGB. Anthropometrics, biochemical measurements, and 3-d food records and liver biopsies were obtained presurgery and, in a subgroup of patients, as for the cohort, 1 y post-RYGB.

Results: In the cross-sectional study, 78.2% were female, with a median age of 48 y and body mass index of 46.8 kg/m2; 33.8% had type 2 diabetes mellitus and 57.1% had metabolic syndrome. In a multivariate analysis, age (odds ratio; 95% CI) (1.076; 1.014-1.141), alanine transaminase (1.068; 1.025-1.112), calorie intake (1.001; 1.000-1.002), and dietary copper (0.127; 0.022-0.752) were independently associated with fibrosis (<0.05). At 1 y post-RYGB, no independent risk factors were associated with persistent fibrosis.

Conclusions: In bariatric patients before surgery, higher age, alanine transaminase, and total calorie and lower copper intakes were independent risk factors associated with liver fibrosis. These relationships were no longer observed after RYGB, likely due to the effect of surgery on weight and similar postsurgery diet among patients.

Keywords: Copper; Dietary intake; Liver fibrosis; Non-alcoholic fatty liver disease; Obesity.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Alanine Transaminase
  • Bariatric Surgery* / adverse effects
  • Copper
  • Cross-Sectional Studies
  • Diabetes Mellitus, Type 2* / etiology
  • Eating
  • Female
  • Gastric Bypass* / adverse effects
  • Humans
  • Liver Cirrhosis / etiology
  • Liver Cirrhosis / surgery
  • Male
  • Obesity / etiology
  • Obesity, Morbid* / complications
  • Obesity, Morbid* / surgery
  • Prospective Studies

Substances

  • Alanine Transaminase
  • Copper

Grants and funding